Dr. Maurie Markman sits down with Dr. Vincent T. DeVita, one of the most influential researchers and physicians in the cancer care arena.
"Sequential treatment in prostate cancer is really something that’s evolving over time," Dr. Daniel Petrylak said of the study findings presented at the European Society of Medical Oncology Congress 2019.
Immunotherapy’s effectiveness may depend on the bacteria living in patients’ gastrointestinal tracts, studies show.
Patients with metastatic breast cancer receiving HER2-targeted therapies should promptly report any respiratory symptoms or signs of lung and heart disease to their oncology care team to facilitate early intervention and management of side effects.
New surgical techniques can limit the risk of postoperative complications in patients with cancer.
There are many reasons patients don’t take their drugs for myeloma and other cancers as prescribed, but there are ways to offer support.
Medication management can easily become overwhelming, but Roberta Carson offers advice to make sure medicine is given as prescribed.
Luis A. Diaz, M.D., head of the division of Solid Tumors at Memorial Sloan Kettering Cancer Center, discusses response rates in patients with microsatellite instability-high (MSI-H) or NTRK fusion gastrointestinal (GI) cancers.
A panel of international oncology experts recently met to exchange thoughts on developments in the field of hepatocellular carcinoma (HCC), the most common form of liver cancer. They discussed screening and staging issues, treatment of advanced HCC and results of recent clinical trials.
Neal D. Shore, MD, FACS, medical director, Carolina Urologic Research Center, provides an overview of biomarkers in prostate cancer.
Tiffany Stump, RN BSN CBCN, of The Ohio State Wexner Medical Center at The James Cancer Hospital, Stefanie Spielman Comprehensive Breast Center, shares her Extraordinary Healer essay nomination of Sara Wolfe, B.S.N., RN, CBCN.
Gary Rodin, M.D., head of the Department of Supportive Care at Princess Margaret Cancer Centre, in Toronto, Canada, discusses CALM, an intervention designed to help patients with advanced-stage cancer cope and talk about their concerns.
Tecentriq plus chemotherapy did not improve event-free survival in triple-negative breast cancer but increased rate of complete tumor removal.
An Extraordinary Healer essay honoring Wanda Greeley, RN, OCN [ Sacred Heart Cancer Center in Pensacola Florida ]
Growing scientific insights have led to the swift development of treatments for advanced melanoma, leaving doctors to iron out details about their application.
Donna and Dr Gasparetto close the discussion by highlighting the importance of physicians utilizing their patients, as well as patients being involved with their multiple myeloma treatment.
Exciting new treatment options for patients with pancreatic cancer are on the rise, thanks to organizations such as the Lustgarten Foundation.
A recent and rare look at long-term lung cancer survivors shows breathlessness among them is persistent and common.
This essay written by registered nurse Candice Roth of Atrium Health’s Levine Cancer Institute, nominates her colleague and fellow registered nurse, Brenda Crump, for CURE®’s 2019 Extraordinary Healer® Award.
Despite being diagnosed with cholangiocarcinoma, a cancer of the bile duct, Maria Falzone, a safe sex speaker and comedienne, maintains her sense of humor.
In an interview with CURE, Lutheran Medical Center oncology patient navigator Laurie Hatch explains the best ways for patients with cancer and survivors to restart their exercise routine and the best ways to get moving again and combat side effects from treatment like fatigue.
This is our full documentary from the 2016 climb of Mount Kilimanjaro.
Tasigna and Mekinist is showing promise for the treatment of patients with BRAF/NRAS wild-type melanoma, according to a recent study.
For one mom, cancer presented an opportunity to teach her daughters empathy.